BioSpace News Archive

Pay-for-pounds pioneer HealthyWage bolsters challenge purportedly set forth by mom Kris Jenner, offers to pay Rob Kardashian an additional $50,000 cash for successfully shedding 50 pounds--no strings attached; Promoting the power of community-based motivation and support by spearheading a #HelpRobGetHealthy social media movement

Moves include new venture with Danforth Center to commercialize RNAi technology, investment in GreenLight Biosciences

Bristol-Myers Squibb Company announced today that its fourth quarter 2018 earnings call has been rescheduled for two hours earlier than previously announced.

Navidea Biopharmaceuticals, Inc. today announced that the Ohio Supreme Court has dismissed a Petition filed by Capital Royalty Partners II, L.P. and affiliated entities.

Increases Fourth Quarter Revenues 10% to $6.0 Billion, 9% for Full Year to $22.6 Billion

Lipocine Inc. announced that it has filed an Investigational New Drug application (“IND”) with the U.S. Food and Drug Administration (“FDA”) to initiate a Phase 2 clinical study of LPCN 1144 in non-alcoholic steatohepatitis (“NASH”) with biopsy confirmed NASH subjects.

iAnthus Capital Holdings, Inc. is pleased to announce it has been named to the 2019 OTCQX® Best 50, a ranking of top performing companies traded on the OTCQX Best Market last year.

Navitor Pharmaceuticals, the leader in the development of mTORC1-targeted therapeutics designed to help patients live longer and healthier lives, announced today the initiation of Part B of its Phase 1 clinical study with its lead candidate, NV-5138, for treatment-resistant depression (TRD).

New Products Designed to Ensure Unique Coating Prevents Deposits, Fogging and Patient Discomfort for the Prescribed Life of Lenses

ACCRU leadership is now collaborating with Quorum Review IRB to provide a central institutional review board option for network members participating in oncology trials